GlucoTrack, Inc. (NASDAQ:GCTK) Sees Large Increase in Short Interest

GlucoTrack, Inc. (NASDAQ:GCTK) was the recipient of a significant growth in short interest during the month of March. As of March 13th, there was short interest totaling 43,428 shares, a growth of 53.5% from the February 26th total of 28,292 shares. Based on an average daily volume of 48,922 shares, the short-interest ratio is presently 0.9 days. Approximately 4.4% of the company’s shares are short sold.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Bank of America Corp DE grew its stake in shares of GlucoTrack by 102,125.0% in the second quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock valued at $25,000 after buying an additional 4,085 shares in the last quarter. Boothbay Fund Management LLC purchased a new stake in shares of GlucoTrack during the 4th quarter valued at about $52,000. Finally, Ikarian Capital LLC acquired a new position in GlucoTrack during the 4th quarter worth approximately $177,000. Hedge funds and other institutional investors own 10.92% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of GlucoTrack in a report on Thursday, January 22nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, GlucoTrack currently has an average rating of “Sell”.

GlucoTrack Trading Down 9.2%

NASDAQ:GCTK traded down $0.10 on Friday, hitting $0.99. 34,071,119 shares of the stock were exchanged, compared to its average volume of 47,082. The stock has a fifty day moving average of $1.83 and a 200-day moving average of $4.39. The stock has a market cap of $1.00 million, a PE ratio of -0.03 and a beta of 0.33. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.08. GlucoTrack has a fifty-two week low of $0.96 and a fifty-two week high of $15.90.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.